Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06576817 · ClinicalTrials.gov registry record · NA
High-intensity Interval Circuit Training in People With Parkinson Disease
A NA study of Parkinson Disease, sponsored by Pacific Northwest University of Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06576817: Recruiting NA study of Parkinson Disease, sponsored by Pacific Northwest University of Health Sciences.
NCT06576817 is a NA study of Parkinson Disease that is actively recruiting participants, run by Pacific Northwest University of Health Sciences. The registered enrollment target is 64 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06576817, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Pacific Northwest University of Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to compare different types of high intensity circuit exercises over an 8-class training series in people with Parkinson disease. The main question it aims to answer is: -Does including arm and hand exercises with leg exercises improve reaction time, balance, functional measures, gait speed and quality of life? This group will be compared to a group that only does leg exercises. Participants will be asked to participate in 8 high intensity circuit exercise classes.
Primary Outcome
Cognitive and fine motor skills
Conditions Studied
Interventions
- OTHER High intensity circuit exercise class - Lower and upper extremity
- OTHER High intensity circuit exercise class - Lower extremity alone
Study Locations (1)
Washington
- Pacific Northwest University of Health Sciences - Yakima
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06576817 shows while recruiting
NCT06576817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which High intensity circuit exercise class - Lower and upper extremity is the first listed.
NCT06576817 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06576817 about?
NCT06576817 is a clinical study titled "High-intensity Interval Circuit Training in People With Parkinson Disease". The goal of the study is to compare different types of high intensity circuit exercises over an 8-class training series in people with Parkinson disease. The main question it aims to answer is: -Does including arm and hand exercises with leg exercises improve reaction time, balance, functional meas...
What is the current status of trial NCT06576817?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2024-02-15. Estimated completion is 2026-08.
What conditions does trial NCT06576817 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT06576817?
The interventions under investigation include: High intensity circuit exercise class - Lower and upper extremity (OTHER), High intensity circuit exercise class - Lower extremity alone (OTHER).
Who is sponsoring clinical trial NCT06576817?
This trial is sponsored by Pacific Northwest University of Health Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06576817 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06576817's enrollment target sits among peer trials
64 120th of 297 higher than 177 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI